Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Brooklyn ImmunoTherapeutics LLC
Brooklyn ImmunoTherapeutics Acquires License for mRNA Technology Platform to Develop Genetically Edited Cells to Treat Multiple Cancers, Blood and Other Disorders
April 29, 2021
From
Brooklyn ImmunoTherapeutics LLC
Via
Business Wire
Tickers
BTX
Brooklyn ImmunoTherapeutics Reports Inducement Grants
April 19, 2021
From
Brooklyn ImmunoTherapeutics LLC
Via
Business Wire
Tickers
BTX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.